Growing evidence indicates that ATF4 interacts with diverse lncRNAs in the digestive system, forming a bidirectional regulatory network that affects tumor growth, inflammation, gluconeogenesis, and treatment resistance. The gene discussed is ATF4; the disease is neoplasm.